Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All protocols
C

Protocol

Hip protectors for older adults in nursing homes

Across 14 trials with 11,808 nursing home residents, padded hip protectors worn in special underwear cut hip fracture risk slightly (RR 0.82), with a confidence interval The range the true effect probably falls in. A wide interval means the estimate is uncertain. reaching no effect: about 11 fewer hip fractures per 1,000 people.

Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →

Compare this record with another, side by side →

At a glance

In plain words

Hip protectors are pads worn in special underwear to soften a fall on the hip. In nursing homes they may slightly lower hip fractures, about 11 fewer for every 1,000 people, but the result is not certain. For people living at home they made little or no difference. Many people stop wearing them.

The letter, taken apart
What was measured
Hip fractures.
How big
Hip fractures were slightly less likely: 0.82 times the rate without protectors.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 24687239.
Who it applies to
Nursing home and residential care residents.
Safety
Skin irritation and poor adherence reported.
The record in one view
Compared with
No hip protectors.
Certainty
Grade C, resting on: Cochrane meta-analysis A study that pools the numbers from several trials into one combined estimate. of randomized trials.
What would change this grade
Could rise to B with: Randomized trial of hip protectors with adherence support. Who: Nursing home residents. Measured: Hip fracture. Length: At least 12 months.
Cost
No price recorded yet.
Sources
1 study cited on this record, listed under Sources.
For clinicians
A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
CHard clinical endpoint Grade C

Across 14 trials with 11,808 nursing home residents, padded hip protectors worn in special underwear cut hip fracture risk slightly (RR 0.82), with a confidence interval reaching no effect: about 11 fewer hip fractures per 1,000 people. In five trials of people living at home there was little or no effect.

Why this letter

Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Why this grade

Grade C on hip fracture in nursing homes. A Cochrane review pooled 14 trials and found a small reduction whose confidence interval reached no effect (RR 0.82, 95% CI 0.67 to 1.00; Santesso et al., 2014; PMID 24687239).

WHY NOT Bthe effect is small and the interval includes no benefit; adherence to wearing them is poor.

WHAT THIS GRADE DOES NOT COVERpeople living at home, where five trials found little or no effect, and falls themselves. It also does not cover newer airbag-style or wearable protector designs, which the pooled trials did not test.

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Who responds: this record's trial reading reports no subgroup that identifies who responds.

Evidence notes: meta-analysis

Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Hip fracture (hard)

Last reviewed: November 2026

Evidence wanted

The trial that would change this grade.

DesignRandomized trial of hip protectors with adherence support
PopulationNursing home residents
EndpointHip fracture
DurationAt least 12 months

A positive trial of this shape, supported by further trials, would move this entry to B.

Why the current trials fall short

A trial with good adherence and a clearer effect could carry it to B.

Clinical trials

ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Hip Fractures among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.

Search recruiting studies of Hip Fractures on ClinicalTrials.gov

Dose, form and timing

What to track

Not applicable; the outcome is hip fracture.

Safety

Safety evidence, by strength

No safety data. Each caution on this record, sorted by what it rests on.

Documented in human studies
Cautions resting on what randomized trials or large studies found in people.

None recorded.

Suspected from case reports
Harms reported in individual patients or uncontrolled observations, not confirmed by a trial.

None recorded.

Mechanistic only
Cautions reasoned from how it works, with no human harm data behind them.

None recorded.

Population cautions
Groups in whom it has not been studied, so its safety there is unknown.

None recorded.

No safety data

No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.

Grade history

How this letter has changedLatest: No. 469 · November 2026 · First graded.
Grade history
No. 469 · November 2026 · First graded
Hip protectors for older adults in nursing homes is added from the gap report: Grade C

New record in the gap-report batch. Across 14 trials with 11,808 nursing home residents, padded hip protectors worn in special underwear cut hip fracture risk slightly (RR 0.82), with a confidence interval reaching no effect: about 11 fewer hip fractures per 1,000 people. In five trials of people living at home there was little or no effect.PMID 24687239

Every change to a letter on this site is dated and published. The full evidence log →

Sources

How this record was checked
Citations
Every paper cited on this page is matched to its PubMed record on every build.
Retractions
None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
Read against the papers
November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
Outside review
Not yet done. No reviewer outside EBL has checked this record.

What each of these checks can and cannot show: evidence integrity.

The evidence, in fullOne paper, linked to its PubMed record.
The evidence

Santesso et al. (Cochrane Database Syst Rev, 2014; PMID 24687239): 19 trials, about 17,000 people; nursing or residential care, 14 trials, 11,808 participants, hip fracture RR 0.82 (95% CI 0.67 to 1.00), moderate quality, about 11 fewer per 1,000; community, five trials, 5,614 participants, RR 1.15 (0.84 to 1.58); probably little or no effect on falls.

How EBL searched for the trials (1 search)

The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.

Searched PubMed in November 2026. 8 records screened, 1 eligible for the graded claim.
Query: "hip protector*"[tiab] AND (randomized controlled trial[pt] OR meta-analysis[pt])
The 8 most recent of 58 records were screened by title; none supersedes the Cochrane review (PMID 24687239).
PubMed watch: does a new study change the grade? (nothing new)

No new paper matching the search behind this grade has been added to PubMed since November 2026.

Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.

Disclosure

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →

Build 9b19d78, November 2026